Safety in human testing is ensured through careful risk assessment and monitoring. Phases of clinical trials are designed to progressively evaluate safety and efficacy. Phase I trials involve a small group of healthy volunteers to assess safety and dosage. Phase II and III trials expand the participant pool to evaluate effectiveness and monitor side effects. Continuous monitoring for adverse effects ensures timely intervention if necessary.
